XML 96 R68.htm IDEA: XBRL DOCUMENT v3.25.4
Balance Sheet Components - Schedule Of Other Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]    
Accrued contract manufacturing costs $ 8,220 $ 1,071
Accrued clinical and research expenses 185 611
Accrued professional services $ 5,845 $ 8,682
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total other accrued liabilities Total other accrued liabilities
Current portion of lease liabilities $ 418 $ 1,572
Royalty obligation payable 3,690 2,951
Current portion of deferred royalty obligation 8,124 6,438
Accrued license fees and royalties 1,964 1,727
Other [1] 1,022 6,947
Total other accrued liabilities $ 29,468 $ 29,999
[1] Amount as of December 31, 2024 includes $5.3 million advance payments received from our partner for inventory supply as discussed in Note 4, “License and Collaboration Arrangements”.